Comparison and interpretation of treatment for group A streptococcus pharyngitis in different diagnosis and treatment guidelines
CHEN Si-yu
YANG Ying
HUANG Qian
DENG Jiang-hong
YAO Kai-hu
Abstract：Group A streptococcus(GAS)is the most common bacterial pathogen of pharyngitis.Unlike other causes of pharyngitis,untreated or poorly treated GAS pharyngitis can often lead to a variety of complications,resulting in a serious disease burden.As a typical self-limiting disease,the treatment goals for GAS pharyngitis include symptom relief,shortening disease duration,preventing complications,and reducing bacterial transmission risks.Recommendations from different guidelines regarding GAS pharyngitis management remain inconsistent,with ongoing debates about the necessity for antimicrobial therapy,optimal timing for using antibiotics,and specific medication regimens,and there is not a clearly dominant therapeutic approach.When considering antimicrobial treatment for patients with GAS pharyngitis,careful evaluation of local GAS complication prevalence and individual patient risks is essential.Additionally,personalized management and treatment strategies are required for special patient groups related to GAS pharyngitis,such as GAS carriers,patients with recurrent infections,and those at high risk of acute rheumatic fever.
Keywords：group A streptococcuspharyngitisdrug treatmentantibioticsprevention
Publication Date：2025-06-06
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 497-501,518 )